Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Envoy Medical Inc. (COCHW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: COCHW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -70% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 2.27 | 52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 |
52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -11102.17% |
Management Effectiveness
Return on Assets (TTM) -129.07% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10658404 |
Shares Outstanding - | Shares Floating 10658404 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. (formerly Sound ID) focuses on hearing restoration technologies. The company has been developing fully implanted cochlear implants and hearing aids.
Core Business Areas
- Fully Implanted Cochlear Implants: Development and commercialization of the Esteem cochlear implant, designed to fully restore hearing loss. Esteem utilizes a sensor and driver to stimulate the auditory nerve, differing from traditional CI's using external components.
- Fully Implanted Hearing Aids: The Acclaim implantable hearing aid, designed to treat moderate to severe sensorineural hearing loss.
Leadership and Structure
Envoy Medical is led by a team of executives focused on engineering and clinical development in implantable hearing devices. Details on organizational structure available on the company website and in investor presentations.
Top Products and Market Share
Key Offerings
- Esteem Cochlear Implant: A fully implanted cochlear implant system designed to restore hearing in individuals with moderate to profound sensorineural hearing loss. Market share is currently small due to regulatory approvals and limited commercial release. Primary competitors include Cochlear Limited (COCH.AX) and Sonova Holding AG (SONVX.SW) which have dominant positions in the traditional Cochlear Implant Market. Specific market share data unavailable.
- Acclaim Implantable Hearing Aid: Designed to treat moderate to severe sensorineural hearing loss and is fully implanted. Limited market share due to regulatory approvals and limited commercial release. Competitors include traditional hearing aid companies like Sonova (SONVX.SW) and Demant (DEMANT.CO).
Market Dynamics
Industry Overview
The hearing aid and cochlear implant industry is growing, driven by an aging population and increasing awareness of hearing loss. Innovation focuses on smaller, more effective, and fully implantable devices.
Positioning
Envoy Medical aims to differentiate itself by developing fully implanted devices, offering cosmetic and functional advantages over traditional hearing aids and cochlear implants.
Total Addressable Market (TAM)
The global hearing aid and cochlear implant market is estimated to be over $10 billion and is expected to grow. Envoy Medical is positioned to capture a share of this market with its fully implanted technologies, pending regulatory approvals and commercial success.
Upturn SWOT Analysis
Strengths
- Fully implanted technology offers cosmetic and functional advantages.
- Potential for improved patient compliance and convenience.
- Strong intellectual property portfolio.
Weaknesses
- High development and manufacturing costs.
- Regulatory hurdles for implantable devices.
- Limited commercial experience.
Opportunities
- Growing market for hearing aids and cochlear implants.
- Increasing demand for discreet and convenient hearing solutions.
- Potential partnerships with established medical device companies.
Threats
- Competition from established players with larger market share.
- Risk of technological obsolescence.
- Potential for product recalls or safety concerns.
Competitors and Market Share
Key Competitors
- COCH.AX
- SONVX.SW
- DNKEY.PK
Competitive Landscape
Envoy Medical faces strong competition from established players with significantly larger market share and resources. Its competitive advantage lies in its fully implanted technology, but it needs to overcome regulatory hurdles and commercialization challenges.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is unavailable.
Future Projections: Future projections depend on successful product development, regulatory approvals, and commercialization.
Recent Initiatives: Recent initiatives include ongoing clinical trials and regulatory submissions for their Esteem and Acclaim products.
Summary
Envoy Medical is a small, innovative company focused on fully implanted hearing solutions. Its strength is in its technology, but it faces challenges due to competition, regulatory hurdles and commercialization requirements. Successful clinical trials and regulatory approvals are key to its future growth and acceptance in the market. The company should look for partnerships to boost market reach and support funding initiatives.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Envoy Medical Inc. Website
- Industry Reports
- Competitor Analysis
Disclaimers:
This analysis is based on publicly available information and may not be entirely accurate or complete. It is not financial advice. Market share data is estimated and may not reflect actual figures.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-23 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.